High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes

Abstract

Despite the widespread use of kinase-targeted agents in clear cell renal cell carcinoma (CC-RCC), comprehensive kinase activity evaluation (kinomic profiling) of these tumors is lacking. Thus, kinomic profiling of CC-RCC may assist in devising a classification system associated with clinical outcomes, and help identify potential therapeutic targets. Fresh frozen CC-RCC tumor lysates from 41 clinically annotated patients who had localized disease at diagnosis were kinomically profiled using the PamStation®12 high-content phospho-peptide substrate microarray system (PamGene International). Twelve of these patients also had matched normal kidneys available that were also profiled. Unsupervised hierarchical clustering and supervised comparisons based on tumor vs. normal kidney and clinical outcome (tumor recurrence) were performed and coupled with advanced network modeling and upstream kinase prediction methods. Unsupervised clustering analysis of localized CC-RCC tumors identified 3 major kinomic groups associated with inflammation (A), translation initiation (B), and immune response and cell adhesions (C) processes. Potential driver kinases implicated include PFTAIRE (PFTK1), PKG1, and SRC, which were identified in groups A, B, and C, respectively. Of the 9 patients who had tumor recurrence, only one was found in Group B. Supervised analysis showed decreased kinase activity of CDK1 and RSK1-4 substrates in those which progressed compared to others. Twelve tumors with matching normal renal tissue implicated increased PIM’s and MAPKAPK’s in tumors compared to adjacent normal renal tissue. As such, comprehensive kinase profiling of CC-RCC tumors could provide a functional classification strategy for patients with localized disease and identify potential therapeutic targets.

Metformin induces lipogenic differentiation in myofibroblasts to reverse mouse and human lung fibrosis

“…Kinase activity of metformin-or vehicle-treated IPF fibroblasts (n=3 per group) was analyzed by the PamStation (PamGene International BV) that uses a methodology that allows robust analysis of the activity of tyrosine as well as serine/threonine kinases in cells and tissues [23][24][25][26] . Hereby, active kinases phosphorylate their distinct peptide substrates presented on a peptide array chip.…”

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

“…Run upstream kinase prediction software to query altered kinomic profiles between conditions for upstream kinases 22,23 .…”

Systems medicine approaches for peptide array-based protein kinase profiling: progress and prospects

“…Excitingly, substrate peptides containing phosphorylation consensus sequences for Src family kinases showed remarkably strong levels of phosphorylation compared with normal tissue types and the Src family kinase inhibitors PP1 and dasatinib induced substantial tumor cell death in nine cell culture models of pediatric brain tumors and thus identified dasatinib as a therapeutic option for this disease. Currently the main use of the Pamgene platform is inr product development for pharmaceutical industries, but also various academic studies using the platform have been published [61][62][63][64][65][66][67]. Arguably, the Pamgene platform is currently the most productive in the field with respect to identifying new drugs for clinical medicine, especially in the context of personalized treatment.…”